AAAAAA

   
Results: 1-7 |
Results: 7
SELECTIVE ETA-RECEPTOR ANTAGONISM REDUCES NEOINTIMAL HYPERPLASIA IN APORCINE CORONARY STENT MODEL
Authors: MCKENNA CJ BURKE SE OPGENORTH TJ PADLEY RJ CAMRUD LDJ CAMRUD AR CARLSON PJ LERMAN A HOLMES DR SCHWARTZ RS
Citation: Cj. Mckenna et al., SELECTIVE ETA-RECEPTOR ANTAGONISM REDUCES NEOINTIMAL HYPERPLASIA IN APORCINE CORONARY STENT MODEL, Journal of the American College of Cardiology, 31(2), 1998, pp. 144-144
A METAANALYSIS OF THE EFFECT OF TERAZOSIN VERSUS PLACEBO ON SYMPTOMS AND FLOW-RATE IN RANDOMIZED, PLACEBO-CONTROLLED TRIALS
Authors: PADLEY RJ MANSKI R BOYLE P ROBERTSON C ROEHRBORN CG
Citation: Rj. Padley et al., A METAANALYSIS OF THE EFFECT OF TERAZOSIN VERSUS PLACEBO ON SYMPTOMS AND FLOW-RATE IN RANDOMIZED, PLACEBO-CONTROLLED TRIALS, The Journal of urology, 159(5), 1998, pp. 985-985
SELECTIVE ETA RECEPTOR ANTAGONISM REDUCES NEOINTIMAL HYPERPLASIA IN APORCINE CORONARY STENT MODEL
Authors: MCKENNA CJ BURKE SE OPGENORTH TJ PADLEY RJ CAMRUD LJ CAMRUD AR JOHNSON J CARLSON PJ LERMAN A HOLMES DR SCHWARTZ RS
Citation: Cj. Mckenna et al., SELECTIVE ETA RECEPTOR ANTAGONISM REDUCES NEOINTIMAL HYPERPLASIA IN APORCINE CORONARY STENT MODEL, Circulation, 97(25), 1998, pp. 2551-2556
DOSE-RESPONSE OF ADVERSE EVENTS (AE) IN TITRATION STUDIES OF TERAZOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH)
Authors: MAURATH C LIN T HOSMANE B JORDAN D PADLEY RJ
Citation: C. Maurath et al., DOSE-RESPONSE OF ADVERSE EVENTS (AE) IN TITRATION STUDIES OF TERAZOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 2-2
THE HYTRIN COMMUNITY ASSESSMENT TRIAL STUDY - A ONE-YEAR STUDY OF TERAZOSIN VERSUS PLACEBO IN THE TREATMENT OF MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
Authors: ROEHRBORN CG OESTERLING JE AUERBACH S KAPLAN SA LLOYD LK MILAM DE PADLEY RJ
Citation: Cg. Roehrborn et al., THE HYTRIN COMMUNITY ASSESSMENT TRIAL STUDY - A ONE-YEAR STUDY OF TERAZOSIN VERSUS PLACEBO IN THE TREATMENT OF MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA, Urology, 47(2), 1996, pp. 159-168
THE COST-EFFECTIVENESS OF TERAZOSIN AND PLACEBO IN THE TREATMENT OF MODERATE TO SEVERE BENIGN PROSTATIC HYPERPLASIA
Authors: HILLMAN AL SCHWARTZ JS WILLIAN MK PESKIN E ROEHRBORN CG OESTERLING JE MASON MF MAURATH CJ DEVERKA PA PADLEY RJ
Citation: Al. Hillman et al., THE COST-EFFECTIVENESS OF TERAZOSIN AND PLACEBO IN THE TREATMENT OF MODERATE TO SEVERE BENIGN PROSTATIC HYPERPLASIA, Urology, 47(2), 1996, pp. 169-178
THE EFFICACY OF TERAZOSIN, FINASTERIDE, OR BOTH IN BENIGN PROSTATIC HYPERPLASIA
Authors: LEPOR H WILLIFORD WO BARRY MJ BRAWER MK DIXON CM GORMLEY G HAAKENSON C MACHI M NARAYAN P PADLEY RJ
Citation: H. Lepor et al., THE EFFICACY OF TERAZOSIN, FINASTERIDE, OR BOTH IN BENIGN PROSTATIC HYPERPLASIA, The New England journal of medicine, 335(8), 1996, pp. 533-539
Risultati: 1-7 |